Abbott Laboratories Management
Management criteria checks 3/4
Abbott Laboratories' CEO is Robert Ford, appointed in Oct 2018, has a tenure of 5.75 years. total yearly compensation is $23.27M, comprised of 6.4% salary and 93.6% bonuses, including company stock and options. directly owns 0.024% of the company’s shares, worth $44.24M. The average tenure of the management team and the board of directors is 5.5 years and 5.5 years respectively.
Key information
Robert Ford
Chief executive officer
US$23.3m
Total compensation
CEO salary percentage | 6.4% |
CEO tenure | 5.8yrs |
CEO ownership | 0.02% |
Management average tenure | 5.5yrs |
Board average tenure | 5.5yrs |
Recent management updates
Recent updates
Abbott Laboratories: When Double-Digit Device Growth Apparently Isn't Enough
Jul 13These 4 Measures Indicate That Abbott Laboratories (NYSE:ABT) Is Using Debt Reasonably Well
Jul 01Abbott Laboratories (NYSE:ABT) Is Doing The Right Things To Multiply Its Share Price
Jun 18Investors Still Waiting For A Pull Back In Abbott Laboratories (NYSE:ABT)
Jun 04Abbott Laboratories: Why I Agree With Wall Street On This One
Jun 04Abbott Laboratories: Buying More Of This Top-Notch Dividend Growth Stock
May 18Abbott Laboratories: Organic Growth Will Be Key To Q1 Earnings
Apr 17Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)
Apr 15Abbott Laboratories: Buy This World-Class Dividend Growth Stock Now
Mar 21Abbott Laboratories (NYSE:ABT) Might Have The Makings Of A Multi-Bagger
Mar 19Here's Why Abbott Laboratories (NYSE:ABT) Can Manage Its Debt Responsibly
Mar 06Abbott Labs' Reversal Is Here - CGM Tailwinds In 2024
Feb 27Abbott Laboratories' (NYSE:ABT) Shares May Have Run Too Fast Too Soon
Feb 08The King Is Back: Abbott Laboratories' Path To >11% Annual Returns
Jan 29The Abbott Laboratories (NYSE:ABT) Full-Year Results Are Out And Analysts Have Published New Forecasts
Jan 26Abbott Laboratories: Another Healthy Dividend Hike From This Dividend King
Dec 28Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)
Dec 27Abbott Laboratories: A 'Must-Have' In A Defensive Dividend Growth Portfolio
Dec 03Is Abbott Laboratories (NYSE:ABT) Using Too Much Debt?
Nov 29Abbott Laboratories: One Of The Safest Dividend Growth Stocks On The Market
Nov 26Abbott Labs Vs. Thermo Fisher: Which Is The Better Healthcare Stock?
Nov 01Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up
Oct 24Abbott: A Diversified Health Care Company With Strong Underlying Growth
Oct 20CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | US$6b |
Mar 31 2024 | n/a | n/a | US$6b |
Dec 31 2023 | US$23m | US$2m | US$6b |
Sep 30 2023 | n/a | n/a | US$5b |
Jun 30 2023 | n/a | n/a | US$5b |
Mar 31 2023 | n/a | n/a | US$6b |
Dec 31 2022 | US$22m | US$2m | US$7b |
Sep 30 2022 | n/a | n/a | US$8b |
Jun 30 2022 | n/a | n/a | US$9b |
Mar 31 2022 | n/a | n/a | US$8b |
Dec 31 2021 | US$25m | US$1m | US$7b |
Sep 30 2021 | n/a | n/a | US$7b |
Jun 30 2021 | n/a | n/a | US$6b |
Mar 31 2021 | n/a | n/a | US$6b |
Dec 31 2020 | US$20m | US$1m | US$4b |
Sep 30 2020 | n/a | n/a | US$3b |
Jun 30 2020 | n/a | n/a | US$3b |
Mar 31 2020 | n/a | n/a | US$4b |
Dec 31 2019 | US$12m | US$1m | US$4b |
Sep 30 2019 | n/a | n/a | US$3b |
Jun 30 2019 | n/a | n/a | US$3b |
Mar 31 2019 | n/a | n/a | US$3b |
Dec 31 2018 | US$8m | US$784k | US$2b |
Sep 30 2018 | n/a | n/a | US$802m |
Jun 30 2018 | n/a | n/a | US$812m |
Mar 31 2018 | n/a | n/a | US$365m |
Dec 31 2017 | US$5m | US$675k | US$344m |
Compensation vs Market: Robert's total compensation ($USD23.27M) is above average for companies of similar size in the US market ($USD13.24M).
Compensation vs Earnings: Robert's compensation has been consistent with company performance over the past year.
CEO
Robert Ford (50 yo)
5.8yrs
Tenure
US$23,268,171
Compensation
Mr. Robert B. Ford has been the Chief Executive Officer of Abbott Laboratories since March 31, 2020 and also serves as its Chairman of the Board since December 10, 2021. He has been President at Abbott Lab...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman of the Board | 5.8yrs | US$23.27m | 0.024% $ 44.2m | |
CFO & Executive VP of Finance | less than a year | US$3.32m | 0.0023% $ 4.2m | |
Executive VP | 11.5yrs | US$7.42m | 0.011% $ 19.6m | |
Executive VP and Group President of Established Pharmaceuticals & Nutritional Products | 9.8yrs | US$5.93m | 0.0072% $ 13.3m | |
Executive VP & Group President of Medical Devices | 5.5yrs | US$5.50m | 0.0035% $ 6.5m | |
Senior VP of Business & Technology Services and Chief Information Officer | less than a year | no data | no data | |
Vice President of Investor Relations. | no data | no data | no data | |
VP and Chief Ethics & Compliance Officer | no data | no data | no data | |
Vice President of Public Affairs & Corporate Marketing | no data | no data | no data | |
Senior Vice President of Commercial Operations | 1.5yrs | no data | no data | |
Executive Vice President of Human Resources | 4.9yrs | no data | 0.0059% $ 10.9m | |
Executive Vice President of Diabetes Care | 9.1yrs | no data | 0.0041% $ 7.6m |
5.5yrs
Average Tenure
54yo
Average Age
Experienced Management: ABT's management team is seasoned and experienced (5.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman of the Board | 4.7yrs | US$23.27m | 0.024% $ 44.2m | |
Independent Director | 7.4yrs | US$349.29k | 0.39% $ 711.0m | |
Independent Director | 7.5yrs | US$341.96k | 0.00020% $ 368.7k | |
Lead Independent Director | 12.6yrs | US$405.96k | 0.00027% $ 497.7k | |
Independent Director | 3.3yrs | US$337.96k | 0% $ 0 | |
Independent Director | 15.8yrs | US$441.44k | 0% $ 0 | |
Independent Director | 1.3yrs | US$283.96k | 0% $ 0 | |
Independent Director | 6.1yrs | US$331.96k | 0.00018% $ 331.8k | |
Independent Director | 12.6yrs | US$362.60k | 0.00015% $ 276.5k | |
Independent Director | 1.8yrs | US$354.96k | 0% $ 0 | |
Independent Director | 4.8yrs | US$331.19k | 0% $ 0 | |
Independent Director | 2.9yrs | US$356.96k | 0% $ 0 |
5.5yrs
Average Tenure
62yo
Average Age
Experienced Board: ABT's board of directors are considered experienced (5.5 years average tenure).